Literature DB >> 6247264

In vitro inactivation of complement by a serum factor present in Junin-virus infected guinea-pigs.

M T Rimoldi, M M de Bracco.   

Abstract

A serum factor(s) of guinea-pigs infected with Junin virus, the etiological agent of Argentine haemorrhagic fever, is endowed with a potent anticomplementary activity. It is resistant to heat (56 degrees, 30 min) and elutes from a Sephadex G-200 column between albumin and haemoglobin. It is ineffective in the presence of EDTA or EGTA and does not sediment at 82,000 g. It has no direct effect on C4 unless functional Cl is present. However, it induces Cl activation that consumes C4 haemolytic activity in normal human and guinea-pig sera. The evidence presented in this report demonstrates that the complement activation observed in experimental Argentine haemorrhagic fever is at least in part due to a direct effect of this serum factor on the classical complement pathway.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6247264      PMCID: PMC1457950     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  13 in total

1.  Cationic proteins of human granulocytes. VI. Effects on the complement system and mediation of chemotactic activity.

Authors:  P Venge; I Olsson
Journal:  J Immunol       Date:  1975-12       Impact factor: 5.422

2.  [Experimental infection of the guinea pig with Junin virus. Clinical picture, dissemination, and elimination of the virus].

Authors:  L B de Guerrero; M Boxaca; M Weissenbacher; M J Frigerio
Journal:  Medicina (B Aires)       Date:  1977 May-Jun       Impact factor: 0.653

3.  An alternative pathway for fibrinolysis. I. The cleavage of fibrinogen by leukocyte proteases at physiologic pH.

Authors:  E F Plow; T S Edgington
Journal:  J Clin Invest       Date:  1975-07       Impact factor: 14.808

4.  Studies of blood coagulation and pathology in experimental infection of guinea pigs with Junin virus.

Authors:  F C Molinas; R A Paz; M T Rimoldi; M M de Bracco
Journal:  J Infect Dis       Date:  1978-06       Impact factor: 5.226

5.  A stoichiometric assay for the fourth component of complement in whole human serum using EAC'la-gp and functionally pure human second component.

Authors:  S Ruddy; K F Austen
Journal:  J Immunol       Date:  1967-12       Impact factor: 5.422

6.  Complement and coagulation. Serum beta-lc-beta-la in disseminated intravascular coagulation.

Authors:  R H Tomar; D Kolchins
Journal:  Thromb Diath Haemorrh       Date:  1972-07-31

7.  The potential pathogenic role of complement in dengue hemorrhagic shock syndrome.

Authors:  V A Bokisch; F H Top; P K Russell; F J Dixon; H J Müller-Eberhard
Journal:  N Engl J Med       Date:  1973-11-08       Impact factor: 91.245

8.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

9.  Alterations in the enzymatic activity of plasma of guinea pigs infected with Junín virus.

Authors:  F Kierszenbaum; D B Budzko; A S Parodi
Journal:  Arch Gesamte Virusforsch       Date:  1970

10.  Lysis of RNA tumor viruses by human serum: direct antibody-independent triggering of the classical complement pathway.

Authors:  N R Cooper; F C Jensen; R M Welsh; M B Oldstone
Journal:  J Exp Med       Date:  1976-10-01       Impact factor: 14.307

View more
  3 in total

1.  Damage of human polymorphonuclear leukocytes by Junin virus.

Authors:  R P Laguens; P H Gonzalez; C Ponzinibbio; J Chambo
Journal:  Med Microbiol Immunol       Date:  1986       Impact factor: 3.402

2.  Pathologic and virologic study of fatal Lassa fever in man.

Authors:  D H Walker; J B McCormick; K M Johnson; P A Webb; G Komba-Kono; L H Elliott; J J Gardner
Journal:  Am J Pathol       Date:  1982-06       Impact factor: 4.307

Review 3.  Epidemiology of Argentine hemorrhagic fever.

Authors:  G Carballal; C M Videla; M S Merani
Journal:  Eur J Epidemiol       Date:  1988-06       Impact factor: 8.082

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.